Evidence map›Paper›PMID 37493664›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

Comparing the clinical value of baseline [

Jie Ding, Jiangdong Qiu, Zhixin Hao, Hua Huang, Qiaofei Liu, Wenjing Liu, Chao Ren, Marcus Hacker, Taiping Zhang, Wenming Wu and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Diagnostic performance of [Frontiers in medicine · 2025
    Pooled it
  3. Review
  4. Head to head comparison of [EJNMMI research · 2026
    Article
  5. Parametric mapping of dynamicCancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  6. Diagnostic Efficacy of FAPI-PET/CT Versus [Diagnostics (Basel, Switzerland) · 2026
    Review
  7. Digital Biopsy and Network Analysis of Dynamic [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  8. Prognostic value of multiparameter [European journal of nuclear medicine and molecular imaging · 2026
    Article
  9. Article
  10. Article
  11. Molecular Imaging: Unveiling Metabolic Abnormalities in Pancreatic Cancer.International journal of molecular sciences · 2025
    Review
  12. Evaluating the diagnostic value ofJapanese journal of radiology · 2025
    Article
  13. Review
  14. Clinical Utility ofMedComm · 2025
    Article
  15. SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  16. Review
  17. Review
  18. Theranostics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Jie Ding *Department of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.
Jiangdong Qiu *Department of General Surgery, PUMC Hospital, Chinese Academy of Medical Sciences and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.
Zhixin HaoDepartment of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.
Hua HuangDepartment of General Surgery, PUMC Hospital, Chinese Academy of Medical Sciences and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.
Qiaofei LiuDepartment of General Surgery, PUMC Hospital, Chinese Academy of Medical Sciences and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.
Wenjing LiuDepartment of General Surgery, PUMC Hospital, Chinese Academy of Medical Sciences and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.
Chao RenDepartment of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.
Marcus HackerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Taiping ZhangDepartment of General Surgery, PUMC Hospital, Chinese Academy of Medical Sciences and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China. tpingzhang@yahoo.com.
Wenming WuDepartment of General Surgery, PUMC Hospital, Chinese Academy of Medical Sciences and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China. doctorwuu@126.com.
Xiang LiDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. xiang.li@meduniwien.ac.at.
Li HuoDepartment of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and PUMC, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China. huoli@pumch.cn.ORCID 0000-0003-1216-083X
Chinese Academy of Medical Sciences & Peking Union Medical College · CNMedical University of Vienna · AT

Funding

CAMS initiative for innovative medicine 2016ZX310174-4CAMS Initiative for Innovative Medicine CAMS-2018-I2M-3-001Capital 's Funds for Health Improvement and Research CFH-2018-2-4014National Natural Science Foundation of China 82071967The National Key Research and Development Program of China 2020YFC2002702Tsinghua University-Peking Union Medical College Hospital Initiative Scientific Research Program 52300300519
6 · The paper itself

Abstract

purposeAnatomical and molecular staging strategies are needed for the personalized treatment of localized pancreatic ductal adenocarcinoma (PDAC). This study evaluated the performance of [

methodsPatients with suspected localized PDAC on CE-CT were recruited for static [

resultsWe included 49 patients with histologically confirmed PDAC adenocarcinomas; 32 underwent 60-min dynamic [

conclusion

Indexed as

AdenocarcinomaCarcinoma, Pancreatic DuctalPancreatic NeoplasmsPancreatitisQuinolinesFluorodeoxyglucose F18Gallium RadioisotopesHumansPositron Emission Tomography Computed TomographyPrognosis68Ga-FAPIFluorodeoxyglucose F18Gallium RadioisotopesQuinolines[18F]F-FDG[68 Ga]Ga-FAPI-04Pancreatic ductal adenocarcinomaPatient prognosisTumor staging

Identifiers

PMID37493664
OpenAlexW4385264453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.